Liu Songtao, Meng Qinghua, Xu Yuan, Zhou Jianxin
Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China.
Department of Severe Liver Disease, Beijing You'an Hospital, Capital Medical University, Beijing, P. R. China.
Gastroenterol Rep (Oxf). 2021 Sep 25;9(6):505-520. doi: 10.1093/gastro/goab040. eCollection 2021 Dec.
In cirrhosis with ascites, hepatorenal syndrome (HRS) is a specific prerenal dysfunction unresponsive to fluid volume expansion. Acute-on-chronic liver failure (ACLF) comprises a group of clinical syndromes with multiple organ failure and early high mortality. There are differences in the characterization of ACLF between the Eastern and Western medical communities. Patients with ACLF and acute kidney injury (AKI) have more structural injuries, contributing to confusion in diagnosing HRS-AKI. In this review, we discuss progress in the pathogenesis, diagnosis, and management of HRS-AKI, especially in patients with ACLF. Controversy regarding HRS-AKI in ACLF and acute liver failure, hepatic carcinoma, shock, sepsis, and chronic kidney disease is also discussed. Research on the treatment of HRS-AKI with ACLF needs to be more actively pursued to improve disease prognosis.
在肝硬化腹水患者中,肝肾综合征(HRS)是一种对扩容治疗无反应的特定肾前性功能障碍。慢加急性肝衰竭(ACLF)是一组伴有多器官功能衰竭且早期死亡率高的临床综合征。东西方医学界对ACLF的特征描述存在差异。ACLF合并急性肾损伤(AKI)的患者有更多的结构损伤,这导致在诊断HRS-AKI时出现混淆。在本综述中,我们讨论了HRS-AKI在发病机制、诊断和管理方面的进展,特别是在ACLF患者中。还讨论了ACLF以及急性肝衰竭、肝癌、休克、脓毒症和慢性肾脏病中关于HRS-AKI的争议。需要更积极地开展ACLF合并HRS-AKI治疗的研究,以改善疾病预后。